GlaxoSmithKline Inc. abandoned its attempt to sell the alli brand and recommitted to promoting the beleaguered OTC weight loss aid, although it continues to drag down consumer health care product sales.
“We’re going to take the business back in hand and rebuild that brand in a much more focused way and see how that plays forward from here,” GSK Chief Financial Officer Simon Dingemans said July 25 during a conference